Application 214087
- Type
- ANDA
- Sponsor
- HAVIX
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | ACETAMINOPHEN; BUTALBITAL; CAFFEINE | CAPSULE;ORAL | 300MG;50MG;40MG | No | No |
| 002 | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | ACETAMINOPHEN; BUTALBITAL; CAFFEINE | CAPSULE;ORAL | 325MG;50MG;40MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 13925-535 | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | butalbital, acetaminophen and caffeine | Seton Pharmaceuticals LLC | ANDA | Current |
| 13925-535 | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | butalbital, acetaminophen and caffeine | Seton Pharmaceuticals LLC | ANDA | Current |
| 13925-536 | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | butalbital, acetaminophen and caffeine | Seton Pharmaceuticals LLC | ANDA | Current |
| 13925-536 | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | butalbital, acetaminophen and caffeine | Seton Pharmaceuticals LLC | ANDA | Current |